Not sure what was up with Davis....ah....ah....ah...Geez that was annoying. But reg the QT-I recall looking at the QT issue about 1 yr ago and thinking it is not going to be a major issue. A black box for that may be placed but it will not affect many patients. I am not worried about it, except how it might be blown out of proportion by investors who don't even understand what the QT issue is.
Many times when new drugs are released Drug Payers...your insurance that pays for your drugs ( less a Co-Pay ) will try to block the drug with their protocols. This will hurt sales of many new drugs. In the case of Nuplazid, it will be the ONLY drug indicated for PDP. Doctors will push hard to get this drug for their patients, esp those who have already tried 1 drug and had to change it due to side effects and that's a very high % of PDP patients and other psychotic patients. I can recall having these types of patients and calling the psychiatrist over and over again trying to get patients stabilized, but they kept having side effects- its a real pain. This drug is going to really be a God send for patients and the doctors treating them. And I believe it will see a very high amount of OFF -LABEL use.
A drug price comparison site goodrx-dot-you know what, showed the Abilify 20 mg BRAND NAME price, 30 tablets, per month for 12 months TOTAL 1 yr range is $15,216 to $17,316. So I think the price quoted (13K) will be a Brand Name price for 1 yr, but for the lowest dose tablet.
Abilify comes in 2mg, 5mg, 10mg, 15mg, 20mg and 30mg. It comes in Oral solution, disintergrating tab, tablet and vial(injection).
....perhaps a little disappointing for those hoping for news. But one thing this presentation wasn't...it was certainly not a reason to sell. My felling is the market sucks and I will see if this perhaps drops to a better entry point to add on. This stock and many Biotechs may not stabilize for another month or so. Please listen to the presentation and judge for yourself.
PFE made a smart move, halted the failed trial and now will let AXON waste their money. So somehow longs here think AXON knows something that PFE doesn't? Please...chance of AXON success is now between zero and none.
The only thing I recall that was a tiny issue was the QT interval , If I am not mistaken Pima caused a slight delay, ie prolongation, its been so long I dont even remember what the final result was. Geez.